微生物検査市場レポート：2030年までの動向、予測、競合分析

微生物検査の動向と予測

世界の微生物検査市場は、2024～2030年のCAGRが8.7%で、2030年までに推定88億米ドルに達すると予想されます。この市場の主要促進要因は、感染症負担の増大と伝染病の発生、微生物学検査における技術進歩の継続、感染症研究に対する政府と民間資金の増加です。世界の微生物検査市場の将来は、呼吸器疾患、血流感染症、消化器疾患、性感染症、尿路感染症、歯周病市場に機会があり、有望視されています。

• Lucintelは、検査量の増加と継続的な技術進歩により、予測期間中、検査機器がより大きなセグメントであり続けると予測しています。
• この市場の中で呼吸器疾患は、COVID-19の大流行とその他の呼吸器疾患を特定し管理する必要性の高まりにより、最も高い成長が見込まれます。
• 北米は、高度な医療施設が存在し、主要な市場参入企業が存在することから、予測期間中に最も高い成長が見込まれます。

微生物検査市場の新たな動向

微生物検査市場は、技術の発展と医療ニーズの変化の両方を反映するいくつかの主要動向を通じて進化しています。このような動向を理解することは、市場の利害関係者にとって不可欠です。

• 自動化とAIの統合：微生物検査における自動化と人工知能の統合は増加傾向にあり、検査の効率、精度、スループットが向上しています。AIアルゴリズムはデータ解析と意思決定の精巧さを高め、結果を迅速化し、信頼性を向上させる。
• 分子診断：PCRやNGSなどの分子診断への関心が高まっています。どちらも病原体の検出に対して高感度で特異的です。これらの診断法はますます利用しやすくなっており、早期の正確な疾患診断に不可欠です。
• ポイントオブケア検査：可能な限り短時間でオンサイトで診断結果を得なければならないというプレッシャーが高まる中、ポイントオブケア検査ソリューションに対するニーズはかつてないほど高まっています。POC検査は利便性を高め、臨床上と遠隔地での意思決定を加速します。
• 個別化医療：動向の一つである個別化医療は、診断と治療方針の決定を個別化することにより、微生物検査にその影響を及ぼしています。新しい検査技術により、遺伝子や微生物学的プロファイルを対象とした治療戦略が可能になります。
• 感染症サーベイランスの重視：感染症サーベイランスとモニタリングの強化は、微生物検査における技術革新の急増に寄与しています。現在、検査開発への取り組みは、新興病原体や抗菌薬耐性の早期検出とモニタリングを可能にするものに集中しています。

したがって、このような力学は、診断、患者ケア、差し迫った健康問題全般のための微生物検査セグメントの限界を押し広げつつあります。

微生物検査市場における最近の動向

微生物検査市場における最近の動向は、技術的進歩や業界慣行における大きな飛躍を示しています。主要開発には以下が含まれる：

• 高度な診断技術の普及マルチプレックスアッセイや改良型PCRシステムなどの新しい診断プラットフォームや技術により、分析時間が短縮され、微生物検査の精度が向上しています。
• 自動化とロボット工学：検査室における自動化とロボット化は、ワークフローをスムーズにし、人的ミスを減らし、スループットを向上させました。
• 規制の更新：規制の枠組みや基準が更新されれば、さまざまな臨床応用における信頼性と有効性が保証され、高度な微生物検査の開発や検証に弾みがつく。
• 研究開発投資の増加：微生物検査技術に貢献する主要要因の中には、より高度で精密な診断ツールを導入した研究開発への多額の投資があります。
• 検査サービスの世界的拡大：新興市場への微生物検査サービスの拡大は、診断薬へのアクセスを容易にし、特に疾病の蔓延が高い地域における世界ヘルスへの取り組みに貢献しています。

このような要因により、微生物検査の能力がさらに向上し、さまざまな地域や用途における検査の有効性とアクセシビリティが高まっています。

微生物検査市場の戦略的成長機会

微生物検査市場が主要な用途にもたらす戦略的成長機会がいくつかあります。このような機会を特定し活用することで、市場のさらなる成長が促進されるであろう。

• 医療診断：医療施設における微生物検査の増加は、特に、より良く迅速な診断を提供する技術の向上により、疾病の診断と管理をさらに改善します。
• 食品安全検査：食品安全検査セグメントでの需要の高まりにより、新たな機会が生まれつつあります。高度なレベルの微生物検査は食品の品質と安全性を決定するものであるため、このような検査はこのセグメントを革新します。
• 環境モニタリング：環境モニタリングは、水、空気、土壌中の汚染物質や病原体を検出する微生物検査の必要性が高まっていると考えられています。このセグメントは、環境衛生セグメントにおける成長という点で計り知れない可能性を秘めています。
• 製薬業界：新しい微生物検査は、医薬品開発や品質管理への応用を目的として製薬業界で評価されています。医薬品製造において提供される革新的な検査ソリューションには成長の機会があります。
• 動物診断：獣医療における微生物検査の採用が増加するにつれ、動物の病気を検出し、より良い治療を提供する機会が増え、この成長市場セグメントを後押ししています。

このような成長機会は、用途の増加とともに微生物検査市場に影響を与え、業界全体の技術革新を促進しています。

微生物検査市場促進要因・課題

これらは市場に影響を与える技術的、経済的、規制的要因の一部です。微生物検査市場促進要因・課題を知ることは、市場展望の理解に役立ちます。

微生物検査市場促進要因は以下の通りです。

1.技術の進歩：1.技術の進歩：PCRや分子アッセイなどの診断技術が進歩し、検査の精度と効率が向上することで市場を牽引します。

2.医療需要の高まり：医療のニーズと感染症に対する意識の高まりが、高度な微生物検査ソリューションへの需要を後押しし、市場拡大に寄与しています。

3.規制支援：支持的な規制の枠組みと基準により、新しい微生物検査技術の開発と導入が促進され、その信頼性と有効性が確保されています。

4.研究開発投資の増加：研究開発への多額の投資は、微生物検査における技術革新を促進し、高度な診断ツールや技術の導入につながっています。

5.世界ヘルスへの取り組み：感染症対策と公衆衛生の向上に向けた世界の取り組みは、特に資源の乏しい新興市場において、微生物検査が拡大する機会を生み出しています。

微生物検査市場における課題は以下の通りです。

1.コスト高：微生物検査のための高度な技術は、調達コストが非常に高くつく可能性があります。そのコストは、資源に制約のある多くの環境や発展途上地域には到底手の届かないものである可能性があります。

2.規制上の課題：規制環境は厳しいが、複雑な承認システムにより、検査市場への新技術の導入が遅れる可能性があります。

3.既存のシステムとワークフローへの統合：新たに登場する微生物検査技術の多くは、既存のシステムやワークフローとの複雑な統合を必要とし、時には大幅な調整が必要となります。

このような市場促進要因・課題が、成長軌道、技術進歩、その他市場全体の力学に関して微生物検査の市場を牽引しています。

セグメント別微生物検査

この調査には、世界の微生物検査の製品タイプ、検査用途、最終用途、地域別の予測が含まれています。

微生物検査市場の国別展望

微生物検査市場は、新たな技術、正確な診断検査に対するニーズの高まり、規制の変化により、世界中で大きな成長を遂げています。以下は、米国、中国、ドイツ、インド、日本の主要市場における最近の動向の要約です。

• 米国：米国市場では、PCRや次世代シーケンシングを含む高度な微生物検査技術に対する需要が高まっています。迅速診断ソリューションと個別化医療への注目は、検査精度とスピードのセグメントにおける技術革新を促し、より良い患者転帰を保証しています。
• 中国：中国の微生物検査市場は急速に成長しています。この市場を牽引しているその他の要因としては、医療インフラや調査研究に対する政府投資の増加、先進的診断技術の採用、感染症対策の強化などが挙げられます。
• ドイツ：ドイツは微生物検査における最新のイノベーションの最前線にあり続け、自動化やAIを検査プロセスに組み込んでいます。臨床と研究の両セグメントで先進的な検査技術の開発と導入を支援する新たな規制の枠組みが整いつつあります。
• インド：感染症に対する意識の高まりと医療サービスの向上により、インドの微生物検査市場は拡大しています。また、手頃な価格の高スループット診断技術により、アクセス性が向上し、疾患の検出とモニタリングの効率化が可能になりました。
• 日本：分子診断学とバイオインフォマティクスへの大規模な投資により、日本の微生物検査市場はさらに発展しています。高齢化や新たな感染リスクなどの課題がある中、検査の精度とスピードの向上に焦点が当てられています。

よくある質問

Q1.市場規模は？

回答：世界の微生物検査市場は、2030年までに推定88億米ドルに達すると予想されています。

Q2.市場の成長予測は？

回答：世界の微生物検査市場は、2024～2030年にかけてCAGR 8.7%で成長すると予測されます。

Q3.市場の成長に影響を与える主要促進要因は？

回答：この市場の主要促進要因は、感染症負担の増大と伝染病の発生、微生物学検査における継続的な技術進歩、感染症研究に対する政府と民間資金の増加です。

Q4.市場の主要セグメントは？

回答：微生物検査市場の将来は、呼吸器疾患、血流感染症、消化器疾患、性感染症、尿路感染症、歯周病の各市場における機会により有望視されています。

Q5.市場の主要企業は？

回答：微生物検査の主要企業は以下の通りです。

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Q6.今後、最大となる市場セグメントは？

回答：Lucintelは、検査量の増加と継続的な技術進歩により、予測期間中、検査機器はより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

回答：北米は、先進的な医療施設の存在と主要な市場参入企業の存在により、予測期間中最も高い成長が見込まれます。

Q8.レポートのカスタマイズは可能か？

回答：はい、Lucintelは追加費用なしで10%のカスタマイズを記載しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の微生物検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の微生物検査市場の動向（2018～2023年）と予測（2024～2030年）
• 製品別の世界の微生物検査市場
  • 機器
  • 試薬
• 検査タイプ別の世界の微生物検査市場
  • 細菌
  • ウイルス
  • 真菌
• 用途別の世界の微生物検査市場
  • 呼吸器疾患
  • 血流感染症
  • 消化器疾患
  • 性感染症
  • 尿路感染症
  • 歯周病
  • その他
• 最終用途別の世界の微生物検査市場
  • 病院
  • 診断センター
  • 学術研究機関
  • その他

第4章 2018～2030年の地域別市場動向と予測分析

• 地域別の世界の微生物検査市場
• 北米の微生物検査市場
• 欧州の微生物検査市場
• アジア太平洋の微生物検査市場
• その他地域の微生物検査市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品別の世界の微生物検査市場の成長機会
  • 検査タイプ別の世界の微生物検査市場の成長機会
  • 用途別の世界の微生物検査市場の成長機会
  • 最終用途別の世界の微生物検査市場の成長機会
  • 地域別の世界の微生物検査市場の成長機会
• 世界の微生物検査市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の微生物検査市場の能力拡大
  • 世界の微生物検査市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Microbiology Testing Trends and Forecast

The future of the global microbiology testing market looks promising with opportunities in the respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and periodontal diseases markets. The global microbiology testing market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are increasing burden of infectious diseases and outbreak of epidemics, on-going technological advancements in microbiology testing, and growing government as well as private-public funding for research on infectious diseases.

• Lucintel forecasts that instruments will remain the larger segment over the forecast period due to increasing testing volume and on-going technological advancements.
• Within this market, respiratory diseases is expected to witness the highest growth due to the covid-19 pandemic and growing requirement to identify and manage other respiratory ailments.
• North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare facilities and existence of key market players in the region.

Emerging Trends in the Microbiology Testing Market

The Microbiology Testing market is evolving through several key trends that reflect both the development of technology and changes in healthcare needs. Understanding such trends is indispensable for the stakeholders of the market.

• Automation and AI Integration: Automation and the integration of artificial intelligence into microbiology testing have been on the rise, thus enhancing the efficiency, accuracy, and throughput of testing. AI algorithms enhance the sophistication of data analysis and decision-making, accelerating results and improving reliability.
• Molecular Diagnosis: There is an increasing interest in molecular diagnosis; these include PCR and NGS. Both are highly sensitive and specific against the detection of pathogens. These diagnostics are becoming increasingly accessible and crucial for early, accurate disease diagnosis
• Point-of-Care Testing: There has never been a greater need for point-of-care testing solutions with the increasing pressure to have diagnostic results on-site in as little time as possible. POC testing increases convenience and accelerates decision-making clinically and remotely.
• Personalized Medicine: One trend, personalized medicine, is having its impact felt on microbiology testing by moving diagnostics and therapeutic decisions onto an individualized basis. New testing technologies make therapeutic strategies targeted at the genetic and microbiological profile possible.
• More Emphasis on Infectious Diseases Surveillance: Increased infectious disease surveillance and monitoring have, therefore, contributed to an upsurge of innovation in microbiology testing. Efforts on test development now focus on those which will enable early detection and monitoring of emergent pathogens and resistance to antimicrobials.

These dynamics, therefore, are pushing the boundaries in the field of Microbiology Testing for diagnostics, patient care, and overall pressing health concerns.

Recent Developments in the Microbiology Testing Market

Recent trends in the Microbiology Testing market indicate giant strides in technological advancement and also industry practices. Key developments include:

• Wider use of advanced diagnostic technologies: Novel diagnostic platforms and technologies, such as multiplex assays, and improved PCR systems are reducing analysis time and enhancing the accuracy of microbiology testing, thereby aiding the better management of diseases.
• Automation and Robotics: Automation and robotics in test laboratories have smoothed the workflow, reduced human error, and increased throughputs, which are very important to deal with the high volume of tests efficiently.
• Regulatory Updates: An updated regulatory framework and standards will further provide a boost to developing and validating advanced microbiology tests by assuring their reliability and effectiveness in various clinical applications.
• Increased Investment in R&D: Among the major factors contributing to microbiology testing technologies are heavy investments in research and development, which introduced more sophisticated and precise diagnostic tools.
• Global Expansion of Testing Services: Expansion in microbiology testing services into emerging markets has been facilitating access to diagnostics, thereby helping global health initiatives, especially in areas with high disease prevalence.

These factors are further developing the capabilities of microbiology testing and enhancing the effectiveness and accessibility of the tests for various regions and applications.

Strategic Growth Opportunities for Microbiology Testing Market

There are a few strategic growth opportunities that the Microbiology Testing market presents for key applications. Identification and capitalization on such opportunities will facilitate further growth of the market.

• Medical Healthcare Diagnostics: Increased microbiology testing in health facilities will further improve the diagnosis and management of diseases, particularly with improved technologies to provide better and quicker diagnoses.
• Food Safety Testing: New opportunities are emerging with growing demands in the food safety testing segment. Advanced-level microbiology testing is what determines the quality and safety of the food products; therefore, such tests innovate in this field.
• Environmental Monitoring: Environmental monitoring is considered to show an increased need for microbiology tests to detect contaminants and pathogens in water, air, and soil. This area has immense potential in terms of growth in the field of environmental health.
• Pharmaceutical Industry: New microbiology tests are being evaluated by the pharmaceutical industry for applications in drug development and quality control. Innovative testing solutions provided in drug manufacturing have opportunities for growth.
• Veterinary Diagnostics: With the increased adoption of microbiology tests in veterinary medicine, more opportunities to detect diseases and provide better treatments for animals will arise, offering a boost in this growing market segment.

These growth opportunities are influencing the Microbiology Testing market with increasing applications and driving innovation across industries.

Microbiology Testing Market Driver and Challenges

These are some of the technological, economic, and regulatory factors affecting the market. Knowing the drivers and challenges of the Microbiology Testing market helps in understanding the market landscape.

The factors responsible for driving the microbiology testing market include:

1. Advancement of Technology: Diagnosis technologies such as PCR and molecular assays advance, thereby driving the market by increasing test accuracy and efficiency; hence, improving treatment due to better management of diseases and bringing better outcomes for patients.

2. Rising Healthcare Demand: Increasing healthcare needs and awareness of infectious diseases are fueling demand for advanced microbiology testing solutions, contributing to market expansion.

3. Regulatory Support: Supportive regulatory frameworks and standards are facilitating the development and implementation of new microbiology testing technologies, ensuring their reliability and effectiveness.

4. Increased R&D Investment: Significant investments in research and development are driving innovation in microbiology testing, leading to the introduction of advanced diagnostic tools and techniques.

5. Global Health Initiatives: Global efforts toward fighting infectious diseases and improving public health create opportunities for microbiology testing to expand, particularly in resource-poor and emerging markets.

Challenges in the microbiology testing market are:

1. High Costs: Advanced technologies for microbiology testing may be extremely expensive to procure. The cost could be beyond the means of many resource-constrained settings or developing regions.

2. Regulatory Challenges: Although the regulatory environment has been difficult, complex approval systems may delay the introduction of new technologies to the test market.

3. Integration into Existing Systems and Workflows: Most of the emerging microbiology testing technologies will require intricate integrations with existing systems and workflows, sometimes requiring considerable adjustments; hence, it may impact the speed with which they are adopted.

These drivers and challenges drive the Marketplace for Microbiology Testing with regard to growth trajectories, technological advances, and other overall market dynamics.

List of Microbiology Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies microbiology testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiology testing companies profiled in this report include-

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Microbiology Testing by Segment

The study includes a forecast for the global microbiology testing by product, test type, application, end use, and region.

Microbiology Testing Market by Product [Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents

Microbiology Testing Market by Test Type [Analysis by Value from 2018 to 2030]:

• Bacterial
• Viral
• Fungal

Microbiology Testing Market by Application [Analysis by Value from 2018 to 2030]:

• Respiratory Diseases
• Bloodstream Infection
• Gastrointestinal Diseases
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Periodontal Diseases

Microbiology Testing Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Academic & Research Institutes
• Others

Microbiology Testing Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Microbiology Testing Market

The market for Microbiology Testing has seen considerable growth worldwide due to emerging technologies, a growing need for accurate diagnostic testing, and changing regulations. The following provides a synopsis of some of the recent developments in the main markets, which are the United States, China, Germany, India, and Japan.

• United States: The USA market is observing a high demand for sophisticated microbiology testing technologies comprising PCR and next-generation sequencing. The focus on rapid diagnostic solutions and personalized medicine encourages innovation in the areas of test accuracy and speed, hence assuring better patient outcomes.
• China: China's microbiology testing market has grown rapidly. Other driving factors for this market are increased government investments in healthcare infrastructure and research, adoption of advanced diagnostic technologies, and enhanced focus on infectious disease control.
• Germany: Germany has continuously remained at the forefront of the latest innovations in microbiology testing, integrating automation and AI into test processes. New regulatory frameworks are being set up to support the development and implementation of advanced technologies for testing across both clinical and research settings.
• India: Growing awareness of infectious diseases, along with an increase in healthcare services in India, has enhanced the country's microbiology testing market. In addition, affordable, high-throughput diagnostic technologies have increased accessibility and allowed for greater efficiency in the detection and monitoring of diseases.
• Japan: With major investments in molecular diagnostics and bioinformatics, Japan's microbiology testing market is being further advanced. There is a focus on increasing the precision and speed of testing amid challenges involving an aging population and new infectious risks.

Features of the Global Microbiology Testing Market

Market Size Estimates: Microbiology testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Microbiology testing market size by various segments, such as by product, test type, application, end use, and region in terms of value ($B).

Regional Analysis: Microbiology testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, test types, applications, end uses, and regions for the microbiology testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiology testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the microbiology testing market size?

Answer: The global microbiology testing market is expected to reach an estimated $8.8 billion by 2030.

Q2. What is the growth forecast for microbiology testing market?

Answer: The global microbiology testing market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the microbiology testing market?

Answer: The major drivers for this market are increasing burden of infectious diseases and outbreak of epidemics, on-going technological advancements in microbiology testing, and growing government as well as private-public funding for research on infectious diseases.

Q4. What are the major segments for microbiology testing market?

Answer: The future of the microbiology testing market looks promising with opportunities in the respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and periodontal diseases markets.

Q5. Who are the key microbiology testing market companies?

Answer: Some of the key microbiology testing companies are as follows:

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Q6. Which microbiology testing market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the larger segment over the forecast period due to increasing testing volume and on-going technological advancements.

Q7. In microbiology testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare facilities and existence of key market players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the microbiology testing market by product (instruments and reagents), test type (bacterial, viral, and fungal), application (respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and others), end use (hospitals, diagnostic centers, academic & research institutes, and others ), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Microbiology Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Microbiology Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Microbiology Testing Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Reagents
• 3.4: Global Microbiology Testing Market by Test Type
  • 3.4.1: Bacterial
  • 3.4.2: Viral
  • 3.4.3: Fungal
• 3.5: Global Microbiology Testing Market by Application
  • 3.5.1: Respiratory Diseases
  • 3.5.2: Bloodstream Infection
  • 3.5.3: Gastrointestinal Diseases
  • 3.5.4: Sexually Transmitted Diseases
  • 3.5.5: Urinary Tract Infections
  • 3.5.6: Periodontal Diseases
  • 3.5.7: Others
• 3.6: Global Microbiology Testing Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Diagnostic Centers
  • 3.6.3: Academic & Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Microbiology Testing Market by Region
• 4.2: North American Microbiology Testing Market
  • 4.2.1: North American Microbiology Testing Market by Product: Instruments and Reagents
  • 4.2.2: North American Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
• 4.3: European Microbiology Testing Market
  • 4.3.1: European Microbiology Testing Market by Product: Instruments and Reagents
  • 4.3.2: European Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
• 4.4: APAC Microbiology Testing Market
  • 4.4.1: APAC Microbiology Testing Market by Product: Instruments and Reagents
  • 4.4.2: APAC Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
• 4.5: ROW Microbiology Testing Market
  • 4.5.1: ROW Microbiology Testing Market by Product: Instruments and Reagents
  • 4.5.2: ROW Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Microbiology Testing Market by Product
  • 6.1.2: Growth Opportunities for the Global Microbiology Testing Market by Test Type
  • 6.1.3: Growth Opportunities for the Global Microbiology Testing Market by Application
  • 6.1.4: Growth Opportunities for the Global Microbiology Testing Market by End Use
  • 6.1.5: Growth Opportunities for the Global Microbiology Testing Market by Region
• 6.2: Emerging Trends in the Global Microbiology Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Microbiology Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiology Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Rad Laboratories
• 7.2: Abbott Laboratories
• 7.3: Becton and Dickinson
• 7.4: F. Hoffmann-La Roche
• 7.5: Bruker Corporation
• 7.6: Hologic Corporation
• 7.7: Danaher Corporation
• 7.8: Biomerieux
• 7.9: Thermo Fisher Scientific
• 7.10: Agilent Technologies